Globus Medical SVP exercises 7,500 options, sells shares at $90

Globus Medical Inc. insider activity: A senior vice president who also serves as general counsel and corporate secretary reported an options exercise and stock sale in Class A common stock.

Rhea-AI Filing Summary

Globus Medical Inc. insider activity: A senior vice president who also serves as general counsel and corporate secretary reported an options exercise and stock sale in Class A common stock. On 11/25/2025, the executive exercised stock options covering 7,500 shares at an exercise price of $25.96 per share, increasing direct ownership of common stock to 7,500 shares.

On the same date, the executive sold 7,500 shares of Class A common stock at $90 per share under a Rule 10b5-1 trading plan dated December 4, 2024. Following these transactions, the reporting person disclosed beneficial ownership of 0 shares of Class A common stock and 0 related stock options.

Insider Trade Summary

Exercise and Sale: 7,500 shares ($480K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Huller Kelly

Role SVP, GC, Corporate Secretary

Sold 7,500 shs ($675K)

Approx. gross sale proceeds $675K

Approx. exercise cost $195K

Approx. pre-tax spread $480K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy Class A Common Stock)	7,500	$0.00	$0.00
Exercise	Class A Common Stock	7,500	$25.96	$195K
Sale	Class A Common Stock	7,500	$90.00	$675K

Holdings After Transaction: Stock Option (Right to Buy Class A Common Stock) — 0 contracts (Direct); Class A Common Stock — 0 shares (Direct)

Footnotes (2)

1. F1. This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated December 4, 2024 executed by the reporting person.
2. F2. These options were granted on February 2, 2017 and are fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Globus Medical (GMED) report in this Form 4?

A senior vice president at Globus Medical Inc. exercised stock options for 7,500 shares of Class A common stock and sold 7,500 shares on 11/25/2025.

At what prices did the Globus Medical (GMED) insider exercise and sell shares?

The executive exercised options at an exercise price of $25.96 per share and sold the resulting 7,500 shares of Class A common stock at $90 per share.

How many Globus Medical (GMED) shares does the insider own after the reported transactions?

After the reported transactions, the insider reported owning 0 shares of Globus Medical Class A common stock and 0 related stock options.

Was the Globus Medical (GMED) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the 7,500-share sale was made pursuant to a Rule 10b5-1 trading plan dated December 4, 2024.

What position does the reporting person hold at Globus Medical (GMED)?

The reporting person is an officer of Globus Medical, serving as SVP, General Counsel, and Corporate Secretary.

When were the stock options in this Globus Medical (GMED) Form 4 originally granted?

The stock options exercised for 7,500 shares were granted on February 2, 2017 and are disclosed as fully vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/28/2025 - 05:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huller Kelly

(Last) (First) (Middle)

VALLEY FORGE BUSINESS CENTER

2560 GENERAL ARMISTEAD AVENUE

(Street)

AUDUBON PA 19403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [ GMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GC, Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/25/2025		M		7,500	A	$25.96	7,500	D
Class A Common Stock	11/25/2025		S(1)		7,500	D	$90	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)	$25.96	11/25/2025		M			7,500	(2)	02/02/2027	Class A Common Stock	7,500	$0	0	D

Explanation of Responses:

1. This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated December 4, 2024 executed by the reporting person.

2. These options were granted on February 2, 2017 and are fully vested.

	/s/ Kelly G. Huller	11/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.